Basel Medical Group Ltd (BMGL)
$3.85+0.00%Close
SELLCRISIS · day 21
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $6M
- Beta
- 0.26
- P/E (TTM)
- -14.12
- Short % float
- 2.59%
- Days to cover
- 1.0
- SI change
- -92.9%
- 1W
- +17.38%
- 1M
- -27.90%
- vs SPY 1W
- +17.52%
- vs SPY 1M
- -30.41%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 0
- GROWTH
- 18
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-104.2%
REV YoY-
ROE-173.6%
EPS YoY-
ROA-48.1%
GROSS-2
OP-32
NET-68
[VALUATION]
P/E TTM-14.12
P/E FWD-
SECTOR PE20.48
INDUSTRY PE35.21
P/B1.23
P/FCF-
EV/EBITDA-9.75
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E157.21
ALTMAN Z-
CURR RATIO1.88
ND/EBITDA-
BETA0.26
Company news
FAQ
- What is LOPJLB’s current signal on BMGL?
- LOPJLB’s latest quantitative signal on Basel Medical Group Ltd Ordinary Shares (BMGL) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is BMGL in?
- Basel Medical Group Ltd Ordinary Shares (BMGL) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Basel Medical Group Ltd Ordinary Shares (BMGL) do?
- Basel Medical Group Ltd, an entity established in Singapore in 2023, is dedicated to delivering a comprehensive range of healthcare services. Its operations span multiple key areas, including specialist medical expertise, medical supplies and equipment, advanced medical technology solutions, and pharmaceutical products.